Filing Details
- Accession Number:
- 0000950170-24-139123
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-20 17:00:04
- Reporting Period:
- 2024-12-18
- Accepted Time:
- 2024-12-20 17:00:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1789972 | Cullinan Therapeutics Inc. | CGEM | Biological Products, (No Disgnostic Substances) (2836) | 813867811 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1844824 | L Jacquelyn Sumer | C/O Cullinan Therapeutics, Inc. One Main Street, Suite 1350 Cambridge MA 02142 | Chief Legal Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-12-18 | 3,482 | $11.41 | 90,651 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.
Billionaire Hedge Funds
